# Cluster3-70 Analysis

## Proteins: 

INTS6, MEF2D, MTO1, WRAP53

### Nucleoplasmic RNA Regulation System

#### Summary

The human protein system under analysis consists of four proteins: INTS6, MTO1, MEF2D, and WRAP53. These proteins are involved in various cellular processes, including protein binding, RNA binding, and cellular localization. The system appears to be primarily located in the nucleoplasm, with three of the four proteins (INTS6, MEF2D, and WRAP53) having this cellular component in common. Additionally, two proteins (MTO1 and WRAP53) are found in the cytosol. The biological processes performed by this system are likely related to RNA regulation and protein-protein interactions.

INTS6, also known as DDX26, is a component of the Integrator complex, which is involved in the processing of small nuclear RNAs (snRNAs) and transcription regulation (1). MTO1 is a mitochondrial translation optimization factor that plays a role in mitochondrial protein synthesis and respiratory chain function (2). MEF2D is a transcription factor that regulates gene expression in various cellular processes, including muscle development, neuronal differentiation, and cell survival (3). WRAP53, also known as TCAB1, is involved in the biogenesis of telomerase and Cajal bodies, as well as the trafficking of small nuclear ribonucleoproteins (snRNPs) (4).

Based on the cellular components and biological processes associated with these proteins, we propose the name "Nucleoplasmic RNA Regulation System" for this protein system. This name reflects the primary cellular location (nucleoplasm) and the function (RNA regulation) of the system. Further investigation is needed to determine if this is a novel complex or if any proteins are novel members of a known complex.

#### References

1. Baillat, D., Hakimi, M. A., Näär, A. M., Shilatifard, A., Cooch, N., & Shiekhattar, R. (2005). Integrator, a multiprotein mediator of small nuclear RNA processing, associates with the C-terminal repeat of RNA polymerase II. *Cell*, 123(2), 265-276. [DOI: 10.1016/j.cell.2005.08.019](https://doi.org/10.1016/j.cell.2005.08.019)

2. Ghezzi, D., Baruffini, E., Haack, T. B., Invernizzi, F., Melchionda, L., Dallabona, C., ... & Zeviani, M. (2012). Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis. *American Journal of Human Genetics*, 90(6), 1079-1087. [DOI: 10.1016/j.ajhg.2012.04.011](https://doi.org/10.1016/j.ajhg.2012.04.011)

3. Potthoff, M. J., & Olson, E. N. (2007). MEF2: a central regulator of diverse developmental programs. *Development*, 134(23), 4131-4140. [DOI: 10.1242/dev.008367](https://doi.org/10.1242/dev.008367)

4. Venteicher, A. S., Abreu, E. B., Meng, Z., McCann, K. E., Terns, R. M., Veenstra, T. D., ... & Artandi, S. E. (2009). A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis. *Science*, 323(5914), 644-648. [DOI: 10.1126/science.1165357](https://doi.org/10.1126/science.1165357)

## Gene Feature Summary: 

| Feature | Number of Genes | Genes |
| --- | --- | --- |
| protein binding | 3 | INTS6, MEF2D, WRAP53 |
| nucleoplasm | 3 | INTS6, MEF2D, WRAP53 |
| nucleus | 2 | INTS6, MEF2D |
| RNA binding | 2 | MTO1, WRAP53 |
| cytosol | 2 | MTO1, WRAP53 |

